MTMR14 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and 2 bp deletion in exon1.
Images
Key facts
- Cell type
- HeLa
- Species or organism
- Human
- Tissue
- Cervix
- Knockout validation
- Sanger Sequencing
- Mutation description
- Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and 2 bp deletion in exon1.
Alternative names
C3orf29, Egg derived tyrosine phosphatase homolog, FLJ11546, FLJ22405, FLJ46453, FLJ90311, HCV NS5A-transactivated protein 4 splice variant A-binding protein 1, MTMRE_HUMAN, Myotubularin-related protein 14, NS5ATP4ABP1, hEDTP, hJumpy, jumpy
What's included?
Recommended products
MTMR14 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and 2 bp deletion in exon1.
Key facts
- Cell type
- HeLa
- Species or organism
- Human
- Tissue
- Cervix
- Knockout validation
- Sanger Sequencing
- Mutation description
- Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and 2 bp deletion in exon1.
- Disease
- Adenocarcinoma
- Concentration
Properties
- Gene name
- MTMR14
- Gene editing type
- Knockout
- Gene editing method
- CRISPR technology
- Knockout validation
- Sanger Sequencing
Quality control
- STR analysis
- CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
- Biosafety level
- EU: 2 US: 2
- Adherent/suspension
- Adherent
- Gender
- Female
Storage
- Shipped at conditions
- Ambient - Can Ship with Ice
- Appropriate short-term storage conditions
- -20°C
- Appropriate long-term storage conditions
- -20°C
Notes
Knockout cell lysate achieved by CRISPR/Cas9.
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
Supplementary info
- This supplementary information is collated from multiple sources and compiled automatically.
- Activity summary
MTMR14 also known as Jumpy or KIAA0788 is a member of the myotubularin-related protein family. This protein functions as a phosphatase where it dephosphorylates phosphatidylinositol 3-phosphate (PI3P) and phosphatidylinositol 35-bisphosphate (PI(35)P2). MTMR14 has a molecular mass of approximately 87 kDa. Researchers find its expression in various tissues with substantial levels in muscle and brain tissue.
- Biological function summary
MTMR14 plays a role in maintaining intracellular membrane dynamics. It forms part of a complex with other myotubularins which regulate phosphoinositide levels. By modulating these lipids MTMR14 helps control endocytosis autophagy and membrane trafficking. This regulation is essential for normal cellular function and homeostasis.
- Pathways
MTMR14 is involved in the PI3K-Akt signaling pathway and the phosphatidylinositol signaling system. It interacts with proteins like Akt and mTOR influencing cellular processes such as growth and metabolism. These pathways are important for cell survival growth and differentiation demonstrating MTMR14's role in comprehensive cellular functions.
- Associated diseases and disorders
MTMR14's dysfunction links to conditions like centronuclear myopathy and Charcot-Marie-Tooth disease. These disorders result from mutations impacting MTMR14's phosphatase activity. MTMR14 interacts with other proteins such as dynamin 2 in these conditions highlighting its relevance to disease pathogenesis and potential as a therapeutic target.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2 product images
Sanger Sequencing - Human MTMR14 knockout HeLa cell lysate (ab258054)
Allele-2: 1 bp deletion in exon1
Sanger Sequencing - Human MTMR14 knockout HeLa cell lysate (ab258054)
Allele-1: 2 bp deletion in exon1
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com